Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06559735 · ClinicalTrials.gov registry record · NA
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
A NA study of Chronic Pain, sponsored by CereVu Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06559735: Recruiting NA study of Chronic Pain, sponsored by CereVu Medical.
NCT06559735 is a NA study of Chronic Pain that is actively recruiting participants, run by CereVu Medical. The registered enrollment target is 25 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06559735, a NA study of Chronic Pain, is actively recruiting participants, sponsored by CereVu Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the study is to determine changes in cerebral nociceptive hemodynamic response (blood oxygenation/flow) before, during and following spinal cord stimulation (SCS). Objective measurements of cerebral nociceptive hemodynamic responses will be obtained with the CereVu sensor and ROPA system and will be analyzed offline and compared against subjective measures of pain. Proprietary analysis algorithms will be incorporated and developed to understand how the objective measurements correlate with subject reported pain levels
Conditions Studied
Interventions
- DEVICE CereVu Device
Study Locations (1)
California
- Boomerang Healthcare - Walnut Creek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What NCT06559735 shows while recruiting
NCT06559735 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which CereVu Device is the first listed.
NCT06559735 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06559735 about?
NCT06559735 is a clinical study titled "Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation". The primary objective of the study is to determine changes in cerebral nociceptive hemodynamic response (blood oxygenation/flow) before, during and following spinal cord stimulation (SCS). Objective measurements of cerebral nociceptive hemodynamic responses will be obtained with the CereVu sensor an...
What is the current status of trial NCT06559735?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-08-13. Estimated completion is 2025-03-31.
What conditions does trial NCT06559735 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT06559735?
The interventions under investigation include: CereVu Device (DEVICE).
Who is sponsoring clinical trial NCT06559735?
This trial is sponsored by CereVu Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06559735 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06559735's enrollment target sits among peer trials
25 257th of 301 higher than 39 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
-
Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI